Longevity Startup Brings Anti-Aging Gene Therapy to Human Trials
Life Biosciences, a Boston-based biotech company founded by Harvard professor David Sinclair, is testing cellular reprogramming to combat aging.
The company's treatment aims to rejuvenate cells without altering their core function, potentially addressing age-related diseases like Alzheimer's, Type 2 diabetes, and Parkinson's.
This potential breakthrough for longevity science also raises ethical concerns, from overpopulation to "hyper-beautification."
Author's summary: Life Biosciences conducts human trials for anti-aging gene therapy.
More News
- Class Intercom to Add Survey & Engagement Functionality Following MindMixer Acquisition
- OpenAI launches Aardvark to detect and patch hidden bugs in code
- GPSC Recruitment 2025: Registration Process For 44 Assistant Professor Ends Soon; Check Age Limit Here
- BVP in Development of Two Laurice Molinari Feature Films and One by Robert Homer Mollohan
- Over 580,000 Blood Pressure Medication Bottles Recalled, FDA Reports
- The science of fear: What makes us afraid, and why do we sometimes like it?
- Sweater Weather: Billboard Crossword (Oct. 30, 2025)
- 'Thief VR: Legacy of Shadow' Comes to All Major VR Headsets in December, New Gameplay Here
- MEG takeover vote postponed again over questions about Cenovus-Strathcona side deal
- Freedom Financial Holdings Announces Earnings for Third Quarter of 2025